4. 4
• Percutaneous Biopsies
• Percutaneous Nephrostomy (PCN)
• Percutaneous Renal Tumor Ablation (Using
Radiofrequency Or Cryoablation)
Occlude Pathological
Arteries
• Bleeding Arteries
• Arterio-venous Fistulae
• Tumour Feeding Artery
Restoring Caliber of Narrow
Arteries
Renal Angioplasty with or without Stent
Insertion
5.
6.
7.
8.
9.
10. • Renal bleeding can occur after
abdominal trauma, which can be
blunt or penetrating.
• Penetrating trauma include
iatrogenic trauma following
percutaneous procedures such
as biopsy, percutaneous
nephrostomy and percutaneous
nephrolithotomy
11. The end result of both blunt and
penetrating/Iatrogenic traumas
can be:
1. Pseudoaneurysm
2. AV Fistula
12. Both pseudoaneurysms and AV
Fistulas can bleed around the
injured kidney leading to
retroperitoneal hematoma
Also both pseudoaneurysms and
AV Fistulas can bleed into the
collecting system when a
concomitant injury to a calyx co-
exists leading to hematuria
13. A 39 years old male with a right renal pseudoaneurysm after PCNL
14. 45 years old male with a post-PCN massive hematuria
15. 34 years old male with a post-nephrectomy swelling
16.
17. • About 40 years ago arterial embolization was
introduced to facilitate the surgical excision of
the carcinomatous kidney or to palliate
symptoms, such as haemorrhage from non-
resectable tumours.
18. • The role of this technique as a therapeutic
procedure has been a source of debate in the
literature.
20. • Symptoms rarely occur in lesions measuring
less than 4 cm in contrast to those measuring 4
cm or larger, of which 80%– 90% are
symptomatic and 50%–60% bleed
spontaneously.
21. • Angiomyolipoma less than 4 cm can be managed
conservatively.
• Larger lesions are at greater risk of spontaneous bleeding
and are treated with Selective embolization particularly in
patients with multiple and bilateral disease.
22.
23.
24.
25. • The basis of treatment for localized disease is surgical
resection, as the tumors are relatively resistant to
both radiotherapy and chemotherapy.
26. • Transarterial embolization (TAE) of renal tumours was
first described in 1973 as a preoperative aid to
resecting localized RCC and to palliate symptoms in
metastatic disease.
31. • Renovascular hypertension (RVHT)
denotes non-essential hypertension
in which a causal relationship exists
between anatomically evident
arterial occlusive disease and
elevated blood pressure.
32. • RVHT is the clinical consequence of
renin-angiotensin-aldosterone
activation as a result of renal
ischemia
33. • Renal artery stenosis (RAS) is a major
cause of RVHT. In older patients,
atherosclerosis is the most common
cause of RAS while Medial fibroplasia
(MFP), as a cause of RAS, usually affects
young to middle-aged adults, mostly
women, but it can also affect children.
34. • PTRA appears to be as
effective as open surgery for
the treatment of isolated renal
artery stenosis.